Rona has permanently altered our customers business practices and restricted access. Managers have been told if this does not improve this fall will see a restructuring. Note kaya comments this spring which left the door open to change. If goals are not met there will be changes.
another rumor. What happened to acquiring an oncology drug? Every company is probably getting emails from ZS to optimize their sales forces. chaching! for ZS Fewer employees mean less for Tres and Kaya to do.
Chaos is necessary and COVID-19 lit the fuse. If you think we can have all the Lundbeck reps, Otsuka and Takeda people (and ignorant managers on ride alongside) all calling on the same people with the same products then you deserve the calamity that will certainly befall upon you. Combine our incompetent level of leadership with a restricted customer base, this party is about to end.
